Clinical Trials Browser

Anemia, Blast Crisis, Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Thrombocytosis, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT01377389 2023-09-29

Ipilimumab + Androgen Depravation Therapy in Prostate Cancer

Phase 2 Terminated

30 enrolled 12 charts

Genitourinary

Prostatic Neoplasms

NCT04311710 2023-02-24

CheckMate 76U

Phase 1 Terminated

21 enrolled

DermatologicGastrointestinalGenitourinaryThoracic

Urinary Bladder Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasms, Skin Neoplasms

NCT04088500 2023-01-10

A Study of Combination Nivolumab and Ipilimumab Retreatment in Patients With Advanced Renal Cell Carcinoma

Phase 2 Terminated

5 enrolled 11 charts

Genitourinary

Carcinoma, Renal Cell

NCT04434560 2022-07-26

Neoadjuvant Immunotherapy in Brain Metastases

Phase 2 Terminated

1 enrolled 7 charts

BreastCNSDermatologicGenitourinaryGynecologicThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Melanoma, Ovarian Neoplasms, Triple Negative Breast Neoplasms

NCT02506114 2021-11-24

Neoadjuvant PROSTVAC-VF With or Without Ipilimumab for Prostate Cancer

Phase 2 Terminated

15 enrolled 13 charts

Genitourinary

Prostatic Neoplasms

NCT01510288 2012-01-16

Phase 1 Trial of Ipilimumab and GVAX in Patients With Metastatic Castration-resistant Prostate Cancer

Phase 1 Terminated

28 enrolled

Genitourinary

Prostatic Neoplasms

Clinical Trials

NEPI

Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors

Study of Entinostat With Nivolumab Plus Ipilimumab in Previously Treated Renal Cell Carcinoma

Nivolumab + Ipilimumab With Immunostimulatory Embolization for Stage 4 Renal Cell Carcinoma With Unresected Primary

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Ipilimumab + Androgen Depravation Therapy in Prostate Cancer

CheckMate 76U

A Study of Combination Nivolumab and Ipilimumab Retreatment in Patients With Advanced Renal Cell Carcinoma

Neoadjuvant Immunotherapy in Brain Metastases

Neoadjuvant PROSTVAC-VF With or Without Ipilimumab for Prostate Cancer

Phase 1 Trial of Ipilimumab and GVAX in Patients With Metastatic Castration-resistant Prostate Cancer